🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cognitive impairment is a key disabling feature of SZ. The impairment affec...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01879709
Treatments Being Tested
This trial is conducted in Europe. The aim of this trial is to investigate ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2009-11
Trial ID
NCT01028404
Treatments Being Tested
The purpose of this study is to examine whether a low dose of CBD+THC will ...
Status
Terminated
Location
University Hospital Campus, London Health Sciences Centre
Start Date
2019-01-10
Trial ID
NCT03808935
Treatments Being Tested
The current available treatments for PTSD are not fully effective for cogni...
Status
Completed
Location
Ralph H. Johnson VA Medical Center, Charleston, SC
Start Date
2014-10-15
Trial ID
NCT02287038
Treatments Being Tested
The purpose of this study is to demonstrate a lack of effect of venlafaxine...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-12
Trial ID
NCT02637193
Treatments Being Tested
The goal of this clinical trial is to learn if adding brain stimulation (ce...
Status
Completed
Location
The University of Hong Kong
Start Date
2024-01-03
Trial ID
NCT07353879
In this randomized, single-blinded clinical trial, 58 patients with major d...
Status
Completed
Location
Seoul St. Mary's Hospital, The Catholic University of Korea
Start Date
2017-11-16
Trial ID
NCT04543123
Treatments Being Tested
This two-phase study aims to explore ways to predict who will respond well ...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2018-01-03
Trial ID
NCT03353220
The purpose of this study is to investigate the effectiveness of a dual-tar...
Status
Not Yet Recruiting
Location
Anhui Medical University
Start Date
2026-03-01
Trial ID
NCT07403591
Treatments Being Tested
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested